spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare Industry News:  permanent birth control 

Devices

 News Release - September 19, 2006

Gyrus ACMI to Partner with Conceptus, Inc. to Market Essure Minimally Invasive Female Sterilization Procedure

SOUTHBOROUGH, Mass.--(HSMN NewsFeed)--Sept. 19, 2006--ACMI Corporation ("Gyrus ACMI"), the Urology & Gynecology division and subsidiary of Gyrus Group, PLC and a leading international manufacturer and supplier of diagnostic and therapeutic minimally invasive surgical devices in the areas of Urology and Gynecology, has entered into a partnership agreement with Conceptus, Inc.

Conceptus, Inc. manufactures and markets the Essure permanent birth control system, an innovative medical device and procedure designed to provide a non-incisional alternative to tubal ligation that can be performed in the Gynecologist office. The Essure procedure deploys a soft micro-insert into the fallopian tube through the cervix using a minimally invasive transcervical tubal access catheter. By terms of the agreement, Conceptus sales representatives will be using Gyrus ACMI SlimLine(TM) Hysteroscopes to provide visualization and access during Physician evaluations of the Essure product in their office. The SlimLine(TM) Hysteroscope, an industry leader for its consistently high flow rates, provides clear visualization of the uterus and fallopian tubes throughout the procedure. Once in place, the Essure device is designed to elicit tissue growth in and around the micro-insert to form an occlusion or blockage in the fallopian tube.

"This is a perfect time for the partnership of Gyrus ACMI and Conceptus, Inc. With insurance reimbursement trends moving positively in the direction of office-based procedures, we recognize the important role that new technologies can play in enabling the Gynecologist to easily move procedures from the hospital to the office while continuing to provide a high level of patient care and safety, " stated Andy Zappas, President & CEO, Urology & Gynecology division of Gyrus Group.

"At Gyrus ACMI, we are committed to developing new women's health care technologies that support Gynecologists' diagnostic and treatment requirements. Our advanced, integrated "see & treat" solutions simplify procedures for both physicians and patients," added Sandra Tilden, V.P. of Marketing, Urology & Gynecology, Gyrus ACMI.

Source: Gyrus ACMI

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

Search: Conceptus 
Search: Gyrus ACMI 
Search: Hysteroscope 
Search: Essure 
Search: Permanent Birth Control 
Healthcare Industry NewsFeed  


FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.